- Advertisement -

Discovery of the role of a key gene in the development of ALS

Loss of function of the C9orf72 gene may affect communication between neurons and muscles Credit: Christian Fleury Amyotrophic...

Portable MiniDock MTB delivers tuberculosis results in thirty minutes

Drugs to treat tuberculosis have been around for more than 75 years, yet it remains the world's top infectious disease killer. A big obstacle...

Research provides evidence to support expansion of insurance coverage of NIPT

Research conducted by the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences provides evidence to support expansion of insurance plan coverage of...

In Vaccine Design, Artificial Proteins Start Mimicking Real Immunogens

Proteins designed from the ground up are usually too regular and continuous to be useful in vaccine design, which must grapple with irregular and...

Race cars, yachts and a pricey biotech investment – The Australian...

It’s more than an offer on a swanky-looking website. Ethical Bioscience is appearing in new-age Instagram feeds and Facebook pages, in online advertisements including...

Parkinson’s in the Clinic, Insilico enters Phase III, Vertex Acquires Crinetics

Promise hits Parkinson’s disease therapy, as a Phase I/II clinical study has demonstrated the feasibility of transplanting stem-cell-derived dopamine progenitor cells into the brain....

See, Blind Mice: Consortium’s Drugs Restore Sight

A consortium led by scientists at the Institute for Bioengineering of Catalonia (IBEC) has developed a series of light-activated small molecule drugs that in...

Parkinson’s in the Clinic, Insilico enters Phase III, Vertex Acquires Crinetics

Promise hits Parkinson’s disease therapy, as a Phase I/II clinical study has demonstrated the feasibility of transplanting stem-cell-derived dopamine progenitor cells into the brain....

See, Blind Mice: Consortium’s Drugs Restore Sight

A consortium led by scientists at the Institute for Bioengineering of Catalonia (IBEC) has developed a series of light-activated small molecule drugs that in...

Protein Design’s AI Revolution: Inside David Baker’s “Communal Brain”

“I have this idea of a communal brain.” David Baker, PhD, told me as I sat in his office at the University of Washington...

more new items

Parkinson’s in the Clinic, Insilico enters Phase III, Vertex Acquires Crinetics

Promise hits Parkinson’s disease therapy, as a Phase I/II clinical study has demonstrated the feasibility of transplanting stem-cell-derived dopamine progenitor cells into the brain....

See, Blind Mice: Consortium’s Drugs Restore Sight

A consortium led by scientists at the Institute for Bioengineering of Catalonia (IBEC) has developed a series of light-activated small molecule drugs that in...

Protein Design’s AI Revolution: Inside David Baker’s “Communal Brain”

“I have this idea of a communal brain.” David Baker, PhD, told me as I sat in his office at the University of Washington...